NEW YORK, Sept. 8 /PRNewswire/ -- Regenicin(TM) (OTC Bulletin Board: WDST), a clinical-stage company developing next-generation tissue-engineered skin substitutes to restore the qualities of healthy human skin, will present at the Rodman & Renshaw Healthcare Conference held at the New York Palace Hotel, New York City from September 12-15, 2010. Regenicin(TM) President Joe Connell will speak ...